Literature DB >> 2315671

Interleukin-2.

K A Smith1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315671     DOI: 10.1038/scientificamerican0390-50

Source DB:  PubMed          Journal:  Sci Am        ISSN: 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  10 in total

1.  Colostral growth factors. Possible role in bovine udder epithelial cell regeneration.

Authors:  A Iivanainen; E Hölttä; A Ståhls; L C Andersson
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

2.  Autocrine ligand binding to cell receptors. Mathematical analysis of competition by solution "decoys".

Authors:  K E Forsten; D A Lauffenburger
Journal:  Biophys J       Date:  1992-02       Impact factor: 4.033

3.  Multiple effects of transfection with interleukin 2 and/or interferon gamma on the behavior of mouse T lymphoma cells.

Authors:  A B Geldhof; J Van Ginderachter; P Vandersteen; G Raes; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

4.  Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide.

Authors:  P V Afonin; A V Fokin; I N Tsygannik; I Y Mikhailova; L V Onoprienko; I I Mikhaleva; V T Ivanov; T Y Mareeva; V A Nesmeyanov; N Li; W A Pangborn; W L Duax; V Z Pletnev
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

Review 5.  The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1996-09       Impact factor: 6.968

Review 6.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

7.  Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course.

Authors:  A J Swaak; R Q Hintzen; V Huysen; H G van den Brink; J T Smeenk
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

Review 8.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

9.  Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: termination of a randomized trial.

Authors:  Kendall A Smith; Sofija Andjelic; Zoran Popmihajlov; Liza Kelly-Rossini; Aquanette Sass; Martin Lesser; Steven Benkert; Cory Waters; Joyce Ruitenberg; Paul Bellman
Journal:  PLoS Clin Trials       Date:  2007-01-26

Review 10.  Feline immune system.

Authors:  D S Lin
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1992-01       Impact factor: 2.268

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.